| |
|
|
|
|
| October 1 ,
2009 | ISSUE NUMBER 118 VOL 6 |
Deals
Abbott Buys Solvay for $6.6 Billion
Solvay has been searching for a suitor for months, so it comes as no surprise that the Belgian drug manufacturer was finally acquired earlier this week. The high bidder—Abbott, a firm that appears to compliment Solvay’s business to a ‘T’—snagged the company for $6.6 billion..
Marketing
Pharma-Targeted Brandjacking on the Rise
Illegal online pharmacies are on the rise, brandjacking dozens of big name pharmaceuticals and netting almost $11 billion in sales this year alone. With consumers on the hunt for affordable meds, the trend is only going to get worse.
Executive Profile
Pharm Exec Q&A: GSK’s Deirdre Connelly
Just months on the job and GSK’s new president of North American Pharmaceuticals Deirdre Connelly is already making her presence known. Her latest move—spearheading an initiative that will boost funding to autonomous CME programs and cut commercial medical education programs. Pharm Exec spoke with Connelly to find out more.
New & Noteworthy
An Open Conversation
Big Pharma navigates a regulatory minefield to reach social media consumers. It's anything but 'business as usual.'
|
 |
|  Variation Biotechnologies appointed Jeff Baxter as CEO
// Eli Lilly promoted David Ricks to president, Lilly USA
// MedCath appointed Art Parker to executive vice president and chief financial officer
// DLA Piper’s New York office made Stuart E. Pollack partner and will lead the firm’s market-leading patent litigation and pharmaceutical practices
// Solara, a CommonHealth business unit, hired Deborah Reale as a senior editor and Claire Pisano as an account executive
// Amsterdam Molecular Therapeutics appointed Jorn Aldag as CEO
// AbelsonTaylor promoted Heather Briddick to copywriter and Matthew Holub to associate copywriter // Micromet appointed Jan Fagerberg, M.D., to senior vice president and chief medical officer // Nile Therapeutics appointed Frank Litvack, M.D., to its board of directors // Tianyin Pharmaceutical appointed Tao Yang to chief operating officer // Portola Pharmaceuticals promoted William Lis to chief operating officer; Daniel D. Gretler, M.D., to chief medical officer; Joseph Lambing to senior vice president, pharmaceutical development; and David R. Phillips to chief scientific officer
|
October 20 Applying E-Commerce Tools to Support Discovery and Development of Medicines: Key Lessons and Learnings
Tuesday, October 20, 2009 at 11AM ET
October 28 Disclosure of Drug Promotion Expenses: How Automated Reporting and Master Data Management Can Improve Compliance and Lower Costs
Wednesday, October 28, 2009 at 11AM EDT
December 2 Risk, Reward and the Pharmaceutical Life Cycle: Managing Information as a Strategic Productivity Asset
Wednesday, December 2, 2009 at 11AM ET
|
October 5–7 BioNetwork 2009: The 7th Annual Pharmaceutical-Biotech Partnering Conference, Laguna Niguel, California
Oct 20–21 CBI’s Leadership Summit on Global Interactions with Healthcare Providers, Arlington, VA
Nov 9–10 Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders,
Princeton, NJ
Dec 8–9 Forum on FDA’s Structured Product Labeling, Washington, DC
|
|
|
|
 |
|
 |
|
 |
| This strategy of proactive engagement with non-traditional constituencies will succeed and preserve the industry business model and operating profits in the vital US market. |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
